Your browser doesn't support javascript.
loading
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection?
AlMuhaissen, Suha; Abu Libdeh, Amal; ElKhatib, Yara; Alshayeb, Rund; Jaara, Areej; Bardaweel, Sanaa K.
Afiliación
  • AlMuhaissen S; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan.
  • Abu Libdeh A; Department of Pediatrics, School of Medicine, Al-Balqa Applied University, Amman, Jordan.
  • ElKhatib Y; Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.
  • Alshayeb R; Department of Pharmaceutics and Pharmaceutical Technology, School of Pharmacy, The University of Jordan, Amman, Jordan.
  • Jaara A; King Hussein Medical Center, Royal Medical Services, Amman, Jordan.
  • Bardaweel SK; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Al-ahliyya Amman University, Amman, Jordan.
Curr Med Res Opin ; 39(8): 1119-1126, 2023 08.
Article en En | MEDLINE | ID: mdl-37501626
OBJECTIVES: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic systemic disease that leads to neurological, immunological, autonomic, and energy metabolism dysfunction. COVID-19 has been reported to cause similar symptoms to ME/CFS. The study aims to investigate the prevalence of myalgic encephalomyelitis in patients post-COVID-19 infection by assessing acute and long-term COVID-19 symptoms. METHODS: A cross-sectional questionnaire was developed based on the ME/CFS diagnostic criteria, as specified by the IOM clinical diagnostic criteria, and administered to participants with confirmed COVID-19 who are more than 18 years old and have BMI below 40 Kg/m2. Data from 437 participants were completed. RESULTS: The current study results revealed that 8.1% of the study participants met the ME/CFS diagnostic criteria. Interestingly, 2.8 of the study participants were classified to have COVID-19 related to ME/CFS. While 4.6% of participants were determined to have disease-related fatigue, 0.7% of participants showed ME/CFS that was not related to COVID-19, and 3.7% of participants were considered to have long COVID-19. Almost one-fourth of the study participants had a family history of ME/CFS. The current study demonstrated that the prevalence of ME/CFS is similar to slightly higher than reported in the literature. CONCLUSION: The presence of a relationship between ME/CFS and COVID-19 has been supported by the results of our study. Follow-up of COVID-19 patients is strongly recommended to ensure proper management of ME/CFS symptoms.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Fatiga Crónica / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Fatiga Crónica / COVID-19 Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: Reino Unido